Back to News
Dec 20, 2025 4:00 AM

Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal

President Donald Trump and nine major pharmaceutical companies announced agreements to lower the cost of medications for cash payers and the government’s Medicaid program on Friday, bringing U.S. costs into line with those of other wealthy countries.

Bristol Myers Squibb Co. (NYSE:BMY), Gilead Sciences Inc. (NASDAQ:GILD), Merck & Co. Inc. (NYSE:MRK), Genentech, Novartis AG (NYSE:NVS), Amgen Inc. (NASDAQ:AMGN), Boehringer Ingelheim, Sanofi SA (NASDAQ:SNY) and GSK plc (NYSE:GSK) struck deals with the administration, Trump said at a White House event.

See Also: Why Health Care ETFs Aren’t Panicking Over Big ...